Dissolving Filler: Criteria for When to Do It

Dissolving a hyaluronic acid filler with hyaluronidase is a resource of enormous value and, for that very reason, one of the interventions that demands the most judgment. In one situation, it is what is done within minutes to try to prevent serious harm. In another, it is a calm decision made after weeks of observation, with an informed patient. And there is a third situation, more frequent than people admit: a request to dissolve on impulse, because of a trend, or because of dissatisfaction that may have another solution.

This page organizes indication criteria into three groups: emergency, elective and when to wait. It gives no doses, dilutions, technique or number of injection points. Those details depend on the product, the area, the individual assessment and the instructions for use, and belong to the qualified professional, following the rules of their professional board.

What does hyaluronidase do and not do?

Hyaluronidase is an enzyme that breaks down hyaluronic acid. This means that:

• it acts on hyaluronic acid-based fillers, to varying degrees depending on the product;
• it does not act on other materials, such as biostimulators or permanent fillers;
• it also breaks down the tissue's natural hyaluronic acid, which explains the temporary loss of volume or change in appearance in some cases;
• it can cause local reactions and, rarely, allergic ones (see hyaluronidase: allergy, testing and precautions and local reaction to hyaluronidase).

Anyone who uses hyaluronic acid should have hyaluronidase available (see hyaluronidase in the practice and hyaluronidase and ANVISA).

How do I tell emergency, elective and wait apart?

The table organizes the reasoning. It is a review guide, not a protocol.

Emergency

When vascular occlusion is suspected, dissolving is part of the emergency protocol, and speed matters. Details are in vascular occlusion, HOF practice emergency kit and in the area-specific pages, such as lip vascular occlusion and visual complication after filler. Disproportionate pain during injection can also be a sign (see severe pain during injection: a warning sign).

Elective with indication

The most common elective situations in which dissolving is usually considered:

• Excess volume that persists after the settling period (see excess volume after filler);
• Asymmetry that does not improve and that the patient notices (see asymmetry after filler);
• Nodule originating from the product (see late hyaluronic acid nodule and inflammatory vs non-inflammatory nodule);
• Tyndall effect, the bluish tint in superficial filler (see Tyndall effect and Tyndall effect in the lips);
• Migration of the product (see hyaluronic acid migration);
• Persistent aesthetic dissatisfaction, when the patient wants to return to a previous state and there is justification.

In these cases, hyaluronidase is one option, not the only one, and should be discussed alongside waiting, massage when indicated, other approaches and maintaining the result.

Wait and reassess

Some findings in the first days and weeks are part of the process and do not indicate dissolving: swelling, bruising, a temporary "too much" look, initial firmness and asymmetry from uneven swelling. Hyaluronic acid is hydrophilic and can increase in volume in the first days. See swelling and late swelling after hyaluronic acid.

What should be assessed before indicating it?

If the product applied is unknown, the decision becomes harder (see patient with unknown prior filler).

How should I talk to the patient?

The conversation about dissolving has three goals: clarify what will be done, align on what to expect and preserve the relationship. Explain that:

• dissolving can be partial or complete, and the result varies;
• there may be swelling and other transient reactions;
• the area may temporarily look different from what is desired;
• a new filler, if desired, usually waits an interval set by the professional.

For communication, see explaining hyaluronidase to the patient, communicating the need for hyaluronidase, patient who wants to undo the filler and patient who wants to dissolve because of a trend.

When should the indication be reassessed?

Some requests to dissolve deserve a conversation before any procedure:

• Trend-driven: the patient wants to "go back to natural" after seeing trends on social media, with no objective complaint.
• Dysmorphia or unrealistic expectation: discomfort with appearance persists regardless of the procedure (see body dysmorphic disorder in HOF).
• External pressure: the request comes from relatives or partners, not from the patient.
• Lack of information: the patient does not know what was applied, or where.

In these cases, the professional's role is to listen, assess, explain alternatives and, if appropriate, decline or refer, always respectfully.

How is it documented?

The record includes the original product (when known), the hyaluronidase used (lot and expiry), the area, the complaint, the exam, consent, instructions, standardized photos and follow-up. See patient record and documentation in HOF and injectable traceability.

In Harmy, the illustrative projection from the frontal photo can help plan and show the patient what is intended, but it does not represent the effect of dissolving and should not be used to promise the result of a correction.